We are live on ! Find out more
FCM

Farallon Capital Management Portfolio holdings

AUM $17.5B
1-Year Est. Return 50.95%
This Fund
S&P 500
This Quarter Est. Return
+12.08%
1 Year Est. Return
+50.95%
3 Year Est. Return
+148.38%
5 Year Est. Return
+206.05%
10 Year Est. Return
+1,475.31%
AUM
$4.83B
AUM Growth
-$49M
Cap. Flow
-$540M
Cap. Flow %
-11.18%
Top 10 Hldgs %
39.24%
Holding
97
New
19
Increased
18
Reduced
23
Closed
18

Sector Composition

Rank Sector Weight
1 Communication Services 17.34%
2 Consumer Discretionary 16.67%
3 Industrials 10.93%
4 Real Estate 10.86%
5 Healthcare 10.17%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EDU icon
51
New Oriental
EDU
$8.91B
$15.8M 0.33%
500,000
OCIP
52
DELISTED
OCI Partners LP
OCIP
$13.8M 0.29%
+500,000
New +$11.9M
RPRX
53
DELISTED
Repros Therapeutics Inc.
RPRX
$12.8M 0.27%
700,000
+230,000
+49% +$4.34M
EIGI
54
DELISTED
Endurance International Group Holdings, Inc.
EIGI
$10.6M 0.22%
+750,000
New +$9.56M
PCO
55
DELISTED
Pendrell Corporation - Class A
PCO
$9.98M 0.21%
4,964
+967
+24% +$1.99M
ANAC
56
DELISTED
ANACOR PHARMACEUTICALS INC COM
ANAC
$9.44M 0.2%
562,352
+112,352
+25% +$1.55M
ASIA
57
DELISTED
ASIAINFO-LINKAGE INC COM STK (DE)
ASIA
$9.39M 0.19%
785,300
+757,638
+2,739% +$8.86M
OREX
58
DELISTED
Orexigen Therapeutics, Inc.
OREX
$9.04M 0.19%
160,500
+65,500
+69% +$3.68M
NKTR icon
59
Nektar Therapeutics
NKTR
$2.44B
$6.92M 0.14%
40,667
HZNP
60
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$6.32M 0.13%
829,420
-1,393,651
-63% -$7.52M
TTM
61
DELISTED
Tata Motors Limited
TTM
$6.08M 0.13%
197,514
VIRX
62
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
$4.98M 0.1%
5,000
+1,595
+47% +$1.65M
CIM
63
Chimera Investment
CIM
$1.06B
$4.65M 0.1%
100,000
-53,667
-35% -$2.44M
OXFD
64
DELISTED
Oxford Immunotec Global PLC Ordinary Shares
OXFD
$4.59M 0.1%
+237,000
New +$4.19M
MACK
65
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
$4.3M 0.09%
102,356
NVGS icon
66
Navigator Holdings
NVGS
$1.33B
$4.04M 0.08%
+150,000
New +$3.49M
FATE icon
67
Fate Therapeutics
FATE
$303M
$3.42M 0.07%
+544,243
New +$3.43M
ARQL
68
DELISTED
Arqule Inc
ARQL
$3.15M 0.07%
1,464,699
DVAX
69
DELISTED
Dynavax Technologies
DVAX
$1.96M 0.04%
+100,000
New +$1.46M
STML
70
DELISTED
Stemline Therapeutics, Inc.
STML
$1.86M 0.04%
95,000
+36,000
+61% +$961K
CF icon
71
CF Industries
CF
$18.1B
$1.66M 0.03%
+35,530
New +$1.55M
BRX icon
72
Brixmor Property Group
BRX
$9.61B
$1.52M 0.03%
+75,000
New +$1.51M
PACT
73
DELISTED
PACTERA TECHNOLOGY INTL LTD SPONSORED ADR
PACT
$1.16M 0.02%
162,809
-997,191
-86% -$6.87M
KIN
74
DELISTED
Kindred Biosciences, Inc.
KIN
$918K 0.02%
+82,445
New +$983K
RCPT
75
DELISTED
RECEPTOS INC COM STK (DE)
RCPT
$290K 0.01%
+10,000
New +$268K

Similar funds

Farallon Capital Management's Q4 2013 Portfolio in Review

As of Q4 2013, Farallon Capital Management held 97 positions worth $4.83B, down 1% from $4.88B the previous quarter. Its ten largest holdings account for 39% of the portfolio.

Farallon Capital Management withdrew a net $540M in Q4 2013, closing 18 positions and reducing 23 holdings. Its most notable exit was DELL INC, an estimated $369M position sold in full.

By sector, the portfolio is most concentrated in Communication Services at 17% of assets, up from 13% a quarter earlier, followed by Consumer Discretionary and Industrials.

Against the trend, Farallon Capital Management opened a new position in eBay worth $181M.

  • Farallon Capital Management's largest Q4 2013 buy was eBay: 7,828,920 shares worth $181M.
  • Farallon Capital Management added most to TIME WARNER CABLE INC NEW COM STK in Q4 2013, an estimated $237M increase.
  • Farallon Capital Management's biggest Q4 2013 reduction was Charter Communications, cutting an estimated $74.3M.
  • Farallon Capital Management fully exited DELL INC in Q4 2013, selling an estimated $369M.
  • Farallon Capital Management's ten largest holdings make up 39% of its $4.83B portfolio in Q4 2013.
  • Farallon Capital Management opened 19 new positions and closed 18 in Q4 2013.
  • Farallon Capital Management's portfolio value fell 1% quarter-over-quarter to $4.83B.

Based on Farallon Capital Management's 13F filing for Q4 2013, filed 14 Feb 2014.